
As an Amazon Associate and affiliate partner, Menrva Books earns from qualifying purchases. Learn more
When is doing the right thing the wrong answer? Jonathan Silverman is a well-respected attorney who finds himself drawn into the tumultuous worlds of pharmaceutical research and criminal enterprise when he's approached by a small start-up that developed a revolutionary dementia treatment seeking his help with a newly filed class-action lawsuit. As Jonathan contemplates representing the company, his father is diagnosed with early-onset Alzheimer's. Despite his world being turned upside down by the devastating prognosis, agreeing to defend the company will provide him with an opportunity to fight for a groundbreaking therapy that may help his father. As the litigation progresses, Jonathan's path collides with MJ Fernandez, an intrepid investigative reporter who questions the lawsuit's timing and the FDA's approval of a new drug by an obscure company about to launch its IPO. MJ is convinced that something is amiss with this company and their wunderkind founder. Reluctantly, they join forces to confront a ruthless investor determined to see the IPO move forward, no matter the cost. Together, they balance on the tightrope of legality in search of the truth, only to find themselves in a no-win situation and fearing for their lives and the lives of those they love. A creative yet treacherous solution emerges, but it requires Jonathan to make an impossible decision-a decision no one should ever have to make.
A respected attorney must choose between defending a revolutionary dementia treatment and helping his ailing father, only to uncover a conspiracy that threatens them both. Jonathan Silverman, a skilled lawyer, is approached by a pharmaceutical start-up with a groundbreaking dementia treatment facing a class-action lawsuit. Simultaneously, his father is diagnosed with early-onset Alzheimer's, presenting Jonathan with a deeply personal stake in the company's defense. His path crosses with MJ Fernandez, an investigative reporter suspicious of the company's rapid rise and drug approval, leading them to confront a ruthless investor. They must navigate a treacherous legal landscape, risking their lives to uncover the truth behind the drug and the company's IPO.
The premise sets up a high-stakes legal and medical thriller where personal stakes are intertwined with corporate intrigue. The narrative appears to focus on the moral complexities faced by the protagonist as he navigates a dangerous investigation. The genre suggests a fast-paced plot with elements of suspense and potential danger for the main characters. The story seems designed to explore themes of ethics, family, and the pursuit of truth in the face of powerful opposition.
Page Count:
430
Publication Date:
2024-11-11
Publisher:
Abundance Collective
ISBN-10:
1965419046
ISBN-13:
9781965419045
No comments yet. Be the first to share your thoughts!